Familial Mediterranean Fever (FMF)
Ophthalmology·MeSH: Fever
Prevalence
30.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| colchicine | Mylan II B.V. (MYL) |
Frequently asked questions
How many drugs are in development for Familial Mediterranean Fever (FMF)?
BioSniper tracks 1 drug in development for Familial Mediterranean Fever (FMF) across 1 company.
How many clinical trials target Familial Mediterranean Fever (FMF)?
There are 1 clinical trial targeting Familial Mediterranean Fever (FMF) tracked by BioSniper.
What is the prevalence of Familial Mediterranean Fever (FMF)?
The estimated prevalence of Familial Mediterranean Fever (FMF) is approximately 30.0 per 100,000 population.
Deep-dive into Familial Mediterranean Fever (FMF)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis